AVB
64
4
KMI
69
2
LRCX
45
6
IBM
60
6
STX
56
4
COF
58
3
TROW
51
3
MU
36
5
NSC
57
7
KO
44
2
GM
68
3
URBN
42
4
SYK
68
4
IPG
53
4
FITB
60
2
SWK
61
5
MCO
75
2
ROP
59
5
EMN
56
7
RL
68
3
AVB
64
4
KMI
69
2
LRCX
45
6
IBM
60
6
STX
56
4
COF
58
3
TROW
51
3
MU
36
5
NSC
57
7
KO
44
2
GM
68
3
URBN
42
4
SYK
68
4
IPG
53
4
FITB
60
2
SWK
61
5
MCO
75
2
ROP
59
5
EMN
56
7
RL
68
3
Financhill
Back

SPDR® S&P Biotech ETF Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

XBI
SPDR® S&P Biotech ETF

Last Price:
95.14
Seasonality Move:
9.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

SPDR® S&P Biotech ETF Stock Forecast

  • Over the next 52 weeks, SPDR® S&P Biotech ETF has on average historically risen by 11.9% based on the past 18 years of stock performance.
  • SPDR® S&P Biotech ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%
  • Is SPDR® S&P Biotech ETF Stock Undervalued?
    The current SPDR® S&P Biotech ETF [XBI] share price is $94.30. The Score for XBI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • XBI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will SPDR® S&P Biotech ETF Stock Go Up Next Year?

  • Over the next 52 weeks, SPDR® S&P Biotech ETF has on average historically risen by 11.9% based on the past 18 years of stock performance.

SPDR® S&P Biotech ETF Stock Rating

Sell
38
SPDR® S&P Biotech ETF (XBI) is a Sell

Is SPDR® S&P Biotech ETF overpriced?

  • SPDR® S&P Biotech ETF has risen higher in 11 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.11%

SPDR® S&P Biotech ETF Stock Price History

Is XBI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XBI is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
105.47
52-Week Low:
71.99

Prediction Charts

Market Cap:
0
Price in USD:
94.30
Volume:
11.65M
Beta:
0.95

Technical Analysis

SMA50:
98.54
SMA100:
98.31
SMA200:
95.01
52-Wk Change:
30.97%

Stock Predictions

  • Is SPDR® S&P Biotech ETF stock public?
    Yes, SPDR® S&P Biotech ETF is a publicly traded company.
  • What is the SPDR® S&P Biotech ETF stock quote today?
    The SPDR® S&P Biotech ETF stock price is 94.30 USD today.
  • How to buy SPDR® S&P Biotech ETF stock online?
    You can buy SPDR® S&P Biotech ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 98.84 99.22 100.07 97.89
Nov-5 98.71 100.62 100.63 98.20
Nov-6 103.28 102.44 103.31 100.75
Nov-7 103.00 103.01 103.89 102.54
Nov-8 102.88 104.18 104.23 102.56
Nov-11 104.84 103.53 105.47 103.35
Nov-12 102.50 100.51 103.17 100.39
Nov-13 101.49 100.01 102.43 100.00
Nov-14 99.77 96.96 100.17 96.87
Nov-15 96.91 91.83 96.91 91.64
Nov-18 92.14 91.96 92.74 91.08
Nov-19 91.24 93.17 93.21 90.67
Nov-20 93.29 94.01 94.17 92.40
Nov-21 94.15 94.30 95.44 92.74

SPDR® S&P Biotech ETF Earnings

Data Unavailable

SPDR® S&P Biotech ETF Forecast Revenue Growth

Data Unavailable

* SPDR® S&P Biotech ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.